Physician profile
Daphne Li
NPI 1457778599
$7,756.89
in general payments reported to CMS, 2019-2025
10 companies · $5,753 in 2025
The $5,753 reported for 2025 was more than what 82% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,147 · 2020: $53.41 · 2021: $406 · 2022: $274 · 2023: $14.58 · 2024: $109 · 2025: $5,753.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $5,580 · Food and Beverage: $296.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $5,580.00 |
| Food and Beverage | $296.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $5,580.00 | 2025 | |
| Stryker Corporation | $1,065.28 | 2019-2020 | |
| Medtronic, INC. | $326.96 | 2021-2025 | Cd Horizon Spinal System |
| Kls-Martin L.P. | $248.65 | 2021-2022 | |
| Osteomed LLC | $147.79 | 2021 | |
| Medtronic USA, INC. | $134.85 | 2019 | |
| Depuy Synthes Sales INC. | $109.10 | 2024 | Cementralizer, Synthecel, Na |
| Livanova USA, INC. | $74.03 | 2022 | |
| Integra Lifesciences Corporation | $55.65 | 2021 | |
| Ethicon US, LLC | $14.58 | 2023 | Surgicel Nu-Knit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daphne Li listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.